- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- (S)-10-[(dimethylamino)methyl]-4-ethyl-9-hydroxy-4-
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
(S)-10-[(dimethylamino)methyl]-4-ethyl-9-hydroxy-4-O-[alpha-(2'', 4'', 5'', 7''-tetranitro-9''-fluorenylideneaminooxy)propionyl]-1H-pyrano[3', 4', 6', 7']indolizino[1,2-beta]-quinoline-3, 14-(4H), 12H)-dione, hydrochloride
| EU orphan designation number: | EU/3/10/788
|
| Active ingredient: | (S)-10-[(dimethylamino)methyl]-4-ethyl-9-hydroxy-4-O-[alpha-(2'', 4'', 5'', 7''-tetranitro-9''-fluorenylideneaminooxy)propionyl]-1H-pyrano[3', 4', 6', 7']indolizino[1,2-beta]-quinoline-3, 14-(4H), 12H)-dione, hydrochloride |
| Indication: | Treatment of hepatocellular carcinoma |
| Sponsor: | TLC Biopharmaceuticals B.V.
Neils Bohrweg 11-13, NL-2333 CA Leiden, Nederland |
Public summary of scientific opinion
European Commission procedures |
CONTACT
EU links
Directorate General Health & Consumers